ZYME: Zymeworks Corp Net earnings per share (EPS TTM)

Zymeworks (ZYME) - corporate logo

Geopolitical fragmentation and sanctions are complicating the global trials of Zymeworks Inc. (ZYME), which dominates the market trend. The rolling net income per share trend captures these complexities, with the latest value recorded as 0.52. Stability is supported by the implementation of AI molecule screening and the aggressive retention of leading immunologists through option programs to combat talent shortages.

ZYME Zymeworks Inc. Net earnings per share for the last 12 months (07/04/2022 - 11/11/2026)

Summary analytical data breakdowns for Zymeworks Inc (ZYME)

- share price and expert price forecast:
Stock Quotes Zymeworks Inc.|ZYME - Fair Value Consensus
- market capitalization information:
Market Capitalization Zymeworks Inc.|ZYME - Company Buyout Price
- business book valuation details:
Net Assets per Single Share Zymeworks|ZYME - Company Net Assets|Market Value to Book Value Ratio zymeworks.com|ZYME - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Zymeworks Inc.|ZYME - Long-Term Debt to Capital|Short-Term Debt to Equity Zymeworks Corp|ZYME - Company Aggregate Debt|Debt to Book Capitalization Ratio Zymeworks Inc.|ZYME - Long-Term Debt|Company Current Liabilities Zymeworks|Quick Liquidity Indicator zymeworks.com
- earnings and multiples data:
ZYME - Profit After Payment of Taxes|Projected Future Earnings Zymeworks Inc.|ZYME - Company Value to Net Income|Forward P/E Multiple Zymeworks|ZYME - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zymeworks Inc.|ZYME - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Zymeworks|ZYME - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months zymeworks.com|ZYME - Earnings per share trend in current year|Expected earnings per share growth for next year Zymeworks Inc.
Fundamental valuation:ZYME - Zymeworks Inc.
Flagship merchandise of Zymeworks Corp

For Zymeworks Inc. (ZYME), which monetizes its multispecific antibody platform through licensing agreements, the net income per share trend reflects the efficiency of converting R&D assets into real capital. The EPS TTM metric aggregates net income over the year and divides it by the number of shares, allowing investors to assess the actual return on ownership and determine the extent of any overpayment for the asset.

Main competitors

IBRX: Net earnings per share for the last 12 months|Earnings per share for the trailing year IMCR (immunocore.com)|JANX: Net earnings per share (EPS TTM)|RCUS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Tango Pharma|Net earnings per share for the last 12 months Iovance Corp (IOVA)|Earnings per share for the last twelve months Immatics N.V. (IMTX)|Net earnings per share for the last 12 months xencor.com XNCR|Compass Therapeutics, Inc. - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Replimune Group Inc REPL|LYEL - Earnings per share for the last twelve months|IPHA (Innate Pharma S.A) - Earnings per share for the last 12 months|pyxisoncology.com (PYXS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Compugen (CGEN)|Net earnings per share for the last 12 months IOBT|STRO - Net earnings per share for the trailing year|Net earnings per share for the last 12 months INKT (MiNK)|Earnings per share for the last four quarters HOWL|Net earnings per share (EPS TTM) IMMX (Immix Biopharma)|Earnings per share for the trailing year ALXO|Cue Biopharma, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months PDS Biotechnology|sonnetbio.com (SONN) - Earnings per share for the last twelve months|MAIA Bio - Earnings per share for the trailing year|LIMN (Liminatus Pharma) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Lava Tx|Earnings per share for the last twelve months NextCure (NXTC)|LPTX: Earnings per one share for the last 12 months|Intensity Therapeutics, Inc. - Net earnings per share for the last 12 months|Sensei Biotherapeutics Inc (SNSE) - Net earnings per one share for the last twelve months|TOVX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months GRTS|KA (Kineta) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months NexImmune Inc (NEXI)|Earnings per share for the last twelve months Turnstone Biologics Corp|Net earnings per share for the last 12 months Vaccinex Inc (VCNX)|Net earnings per share (EPS TTM) HARP